Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant

Aytaj Mammadzadeh, Yara Shatnawi, Rawan Atallah, Benlazar Mohamed, Nihar Desai, Shahrukh K Hashmi, Thiago Xavier Carneiro, Hira Shaikh, Christopher Strouse, Rakesh Popat, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed

Blood (2023) 142 (Supplement 1): 4727.

https://doi.org/10.1182/blood-2023-185151

Published: 2023

Journal Articles

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

Robert Zeiser, Domenico Russo, Ron Ram, Shahrukh K Hashmi, Ronjon Chakraverty, Jan Moritz Middeke, Maurizio Musso, Sebastian Giebel, Ant Uzay, Peter Langmuir, Nada Hamad, Xuechan Li, Maanasa Gowda, Tommaso Stefanelli, Stephanie J. Lee, Takanori Teshima, Franco Locatelli

Blood (2023) 142 (Supplement 1): 654.

https://doi.org/10.1182/blood-2023-172590

Published: 2023

Journal Articles

The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally

Rawan Atallah, Yara Shatnawi, Aytaj Mammadzadeh, Shahrukh K Hashmi, Shabeeha K Rana, Muhammad Umair Mushtaq, Benlazar Mohamed, Nihar Desai, Thiago Xavier Carneiro, Rakesh Popat, Joseph P McGuirk, Shebli Atrash, Zahra Mahmoudjafari, Al-Ola Abdallah, Nausheen Ahmed

Blood (2023) 142 (Supplement 1): 3327.

https://doi.org/10.1182/blood-2023-179050

Published: 2023

Journal Articles

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions

Blood (2022) 140 (Supplement 1): 8019–8021.

https://doi.org/10.1182/blood-2022-167411

Published: 2022

Journal Articles

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Blood (2022) 140 (Supplement 1): 11471–11473.

https://doi.org/10.1182/blood-2022-162734

Published: 2022

Journal Articles

Fecal Microbiota Transplantation As a Therapeutic Option for Graft-Versus-Host-Disease: A Systematic Review and Future Directions

Hafiz muhammad Aslam, Sindhusha Veeraballi, Shahrukh K. Hashmi

Blood (2021) 138 (Supplement 1): 4869.

https://doi.org/10.1182/blood-2021-151904

Published: 2021

Journal Articles

Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study

Robert Zeiser, PhD, Nicola Polverelli, MD PhD, Ron Ram, MD, Shahrukh K. Hashmi, MDMPH, Ronjon Chakraverty, BMBS, PhD, Mary E. D. Flowers, MD, Fitzroy Dawkins, MD, Norbert Hollaender, MD, Maanasa Gowda, PharmD, Tommaso Stefanelli, MD, Stephanie J. Lee, MDMPH, Takanori Teshima, MD, Franco Locatelli, MD PhD

Blood (2020) 136 (Supplement 1): 22–24.

https://doi.org/10.1182/blood-2020-137694

Published: 2020

Journal Articles

Ruxolutinib in Steroid Refractory Graft Versus Host Disease (SR-GVHD): Systemic Literature Review

Mostafa F. Mohammed Saleh, MD PhD, Shahrukh K. Hashmi, MDMPH

Blood (2019) 134 (Supplement_1): 5682.

https://doi.org/10.1182/blood-2019-129538

Published: 2019

Journal Articles

Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases

Hafiz Muhammad Fazeel, MD, Muhammad Abu Zar, MD, Saad Ullah Malik, MD, Ahmad Kamal, MD, Mustafa Nadeem Malik, MD, Syed Shabee Hassan, MD, Syeda Sabeeka Batool, MD, Ceren Durer, MD, Seren Durer, MD, Shehroz Aslam, MD, Madeeha Shafqat, Faiqa Ijaz, MBBS, Faiz Anwer, MD, Shahrukh K. Hashmi, MDMPH

Blood (2018) 132 (Supplement 1): 2194.

https://doi.org/10.1182/blood-2018-99-114511

Published: 2018

Journal Articles

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD MPH, Anja C. Roden, MD, Mrinal M. Patnaik, MD MBBS, Reona Sakemura, MD PhD, Nandita Khera, MD, Vivek Roy, MD, Cassie C. Kennedy, MD, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Hemang Yadav, MBBS

Blood (2018) 132 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2018-99-118930

Published: 2018

Journal Articles

A Phase II of Combination Daunorubicin and Cytarabine (Ara-C) and Nilotinib (TASIGNA) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Final Results

Aref Al-Kali, MD, Raoul Tibes, MD PhD, Jeanne Palmer, MD, Hassan B. Alkhateeb, MD, Mrinal M. Patnaik, MD MBBS, Kebede H. Begna, MD, Naseema Gangat, MBBS, Pamela Atherton, Shujun Liu, PhD, Rong He, MD, Shahrukh K. Hashmi, MD MPH, Mark R. Litzow, MD

Blood (2018) 132 (Supplement 1): 1443.

https://doi.org/10.1182/blood-2018-99-118552

Published: 2018

Journal Articles

Trends in Multiple Myeloma Incidence in the United States (US): Demographic and Geographic Considerations and Focus on Young Adults

Gordon Ruan, MD, Gaurav Goyal, MBBS, Shahrukh K. Hashmi, MD MPH, Prashant Kapoor, MD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 5575.

https://doi.org/10.1182/blood-2018-99-114105

Published: 2018

Journal Articles

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Jason Tay, MD, Ruta Brazauskas, PhD, Naya He, Sara Beattie, Christopher Bredeson, MD FRCPC, MSc, Jignesh Dalal, MD, Shahrukh K. Hashmi, MD MPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 4788.

https://doi.org/10.1182/blood-2018-99-117027

Published: 2018

Journal Articles

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

David K. Buchbinder, MD MSHS, Ruta Brazauskas, PhD, Khalid Bo-Subait, Karen K. Ballen, MD, Theresa E. Hahn, PhD, Tami D John, MD, Susan K Parsons, MD MRP, Shahrukh K. Hashmi, MD MPH, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 2260.

https://doi.org/10.1182/blood-2018-99-116531

Published: 2018

Journal Articles

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Kira O Bona, MDMPH, Ruta Brazauskas, PhD, Naya He, Leslie E. Lehmann, MD, Joanne Wolfe, MD MPH, Jignesh Dalal, MD, Shahrukh K. Hashmi, MDMPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Christine Duncan, MD MSc, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 714.

https://doi.org/10.1182/blood-2018-99-118544

Published: 2018

Journal Articles

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

Ayman Saad, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Lawrence S. Lamb, Jr., PhD, Shahrukh K. Hashmi, MD MPH

Blood (2018) 132 (Supplement 1): 3410.

https://doi.org/10.1182/blood-2018-99-113513

Published: 2018

Journal Articles

Narrowing the Gap for Hematopoietic Cell Transplantation in the East-Mediterranean/African Region: Comparison with Global HSCT Indications and Trends. A Report on Behalf of the East Mediterranean (EMBMT), African Blood and Marrow Transplantation Group (AFBMT) and Worldwide Network for Blood and Marrow Transplantation (WBMT)

Blood (2017) 130 (Supplement 1): 3389.

https://doi.org/10.1182/blood.V130.Suppl_1.3389.3389

Published: 2017

Journal Articles

A Pilot Study Evaluating the Impact of Hospital Hospitality Houses (HHH) Programs on the Quality of Life and Mood of Patients and Their Caregivers Following Hematopoietic Stem Cell Transplant (HCT)

Maria Emma Torres, Shahrukh K. Hashmi, MDMPH, Angelina Tan, Jeff A. Sloan, PhD, Maria Stevens, Valerie Callahan, Gerardo Colon-Otero, MD

Blood (2017) 130 (Supplement 1): 5607.

https://doi.org/10.1182/blood.V130.Suppl_1.5607.5607

Published: 2017

Journal Articles

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Muhned Alhumaid, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Hazzaa Alzahrani, MD, Naeem A. Chaudhri, MD, Raid El Fakih, MD, Amr Hanbali, MD, Shahrukh K. Hashmi, MDMPH, Said Yousuf Ahmed, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Marwan Shaheen, MD, Tusneem Elhassan, MSc, Feras Abdulaziz Alfraih, MD

Blood (2017) 130 (Supplement 1): 5498.

https://doi.org/10.1182/blood.V130.Suppl_1.5498.5498

Published: 2017

Journal Articles

Hematopoietic Cell Transplant for Adult Patients with Severe Sickle Cell Disease: Improving Outcomes and Improving Options

Hafiz M Aslam, MD MBBS, Shahrukh K. Hashmi, MDMPH, Adetola A. Kassim, MD MS

Blood (2017) 130 (Supplement 1): 5540.

https://doi.org/10.1182/blood.V130.Suppl_1.5540.5540

Published: 2017

NARROW

Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Fecal Microbiota Transplantation As a Therapeutic Option for Graft-Versus-Host-Disease: A Systematic Review and Future Directions

Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study

Ruxolutinib in Steroid Refractory Graft Versus Host Disease (SR-GVHD): Systemic Literature Review

Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

A Phase II of Combination Daunorubicin and Cytarabine (Ara-C) and Nilotinib (TASIGNA) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Final Results

Trends in Multiple Myeloma Incidence in the United States (US): Demographic and Geographic Considerations and Focus on Young Adults

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

A Pilot Study Evaluating the Impact of Hospital Hospitality Houses (HHH) Programs on the Quality of Life and Mood of Patients and Their Caregivers Following Hematopoietic Stem Cell Transplant (HCT)

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Hematopoietic Cell Transplant for Adult Patients with Severe Sickle Cell Disease: Improving Outcomes and Improving Options

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only